Rivaroxaban versus warfarin in postoperative atrial fibrillation: Cost-effectiveness analysis in a single-center, randomized, and prospective trial

JTCVS Open（2023）

引用 0|浏览9

暂无评分

摘要

Coronary artery bypass graft (CABG); direct oral anticoagulant (DOAC); postoperative atrial fibrillation (POAF); quality-adjusted life years (QALY).

查看译文

关键词

postoperative atrial fibrillation,anticoagulation,direct oral anticoagulant,coronary artery bypass surgery,cost-effective,costs

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要